Objectives: Inflammatory mediators are associated with many chronic diseases; however, their role in metabolic syndrome (Met-S) is not well documented. We therefore aimed to compare the serum markers of inflammation including C-reactive protein (CRP), myeloperoxidase (MPO), interleukin-6 (IL-6), tumour necrosis factor alpha (TNF-), and TNF- in young military recruits with and without Met-S. We hypothesized that any significant change in inflammatory markers between the two groups would indicate the role of inflammation in Met-S that would help in future directions for screening and treatment of Met-S. . A total of 2010 adult men, aged 18-30 years, were divided into two groups: with Met-S ( = 488) and without Met-S ( = 1522), according to the International Diabetes Federation definition. We compared the serum levels of inflammatory biomarkers between the two groups. We also studied the correlations between the inflammatory markers and the components of Met-S to explore the biomarker potential of inflammatory markers for screening of Met-S. Logistic regression analysis was performed to test the association between inflammatory markers and Met-S.

Results: A large number of subjects in the Met-S group were suffering from obesity. Out of the 2010 total subjects, only 731 (36.4%) had normal fasting blood sugar (FBS), while the prevalence of prediabetes and diabetes was significantly higher in subjects with Met-S. We observed significant increases in serum levels of CRP, MPO, IL-6, and TNF- but not TNF- in subjects with Met-S as compared to subjects without Met-S. All the markers of inflammation showed significant correlations with Met-S, triglycerides (TG), blood pressure, body mass index (BMI), and age; however, none of these markers were correlated with HDL. Logistic regression analysis showed a significant association between Met-S and inflammatory markers.

Conclusions: Serum levels of CRP, MPO, IL-6, and TNF- are significantly increased in young adults with Met-S. This is probably the first study reporting TNF- levels in Met-S. Since a proinflammatory cascade precedes many years before the onset of cardiovascular disease, these inflammatory biomarkers could help in the monitoring of high-risk individuals with Met-S who will be requiring therapeutic intervention.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164864PMC
http://dx.doi.org/10.1155/2023/4613842DOI Listing

Publication Analysis

Top Keywords

met-s
17
serum levels
16
inflammatory markers
16
subjects met-s
16
military recruits
8
metabolic syndrome
8
inflammatory
8
markers inflammation
8
tnf- tnf-
8
inflammatory biomarkers
8

Similar Publications

Background: Isotopologues resulting from the labelling of molecules with deuterium have attracted interest due to the isotope effect observed in chemistry and biosciences. Isotope effect may also play out in noncovalent interactions and mechanisms leading to intermolecular recognition. In chromatography, differences in retention time between isotopologues, as well as between isotopomers have been observed resulting in two different elution sequences (isotope effects): the normal isotope effect when heavier isotopologues retain longer than lighter analogues, and the inverse isotope effect featuring the opposite elution order.

View Article and Find Full Text PDF

Molecular insights into Parkinson's disease and type 2 diabetes mellitus: Metformin's role and genetic pathways explored.

Exp Neurol

January 2025

Institute for Brain Sciences Research, Center for Translational Neurourology, Huaihe Hospital of Henan University, School of Life Sciences, Henan University, Kaifeng 475004, China. Electronic address:

Article Synopsis
  • The study investigates the potential bidirectional relationship between Parkinson's disease (PD) and type 2 diabetes mellitus (T2DM), analyzing shared genetic mechanisms and verifying specific genes involved in the conditions.
  • Using Mendelian randomization, researchers found a positive correlation between PD and T2DM, identifying hub genes that are up-regulated in an animal model, which may indicate shared pathogenic processes.
  • The research highlights metformin's potential role in treating PD aggravated by T2DM by targeting specific genes and pathways related to inflammation and oxidative stress, with molecular docking analysis confirming the stability of metformin's interaction with key proteins.
View Article and Find Full Text PDF

Doxorubicin (DOX) is a commonly used chemotherapeutic medication for treating malignancies, although its cardiotoxicity limits its use. There is growing evidence that alteration of the mitochondrial fission/fusion dynamic processes accompanied by excessive reactive oxygen species (ROS) production and alteration of calcium Ca homeostasis are potential underlying mechanisms of DOX-induced cardiotoxicity (DIC). Metformin (Met) is an AMP-activated protein kinase (AMPK) activator that has antioxidant properties and cardioprotective effects.

View Article and Find Full Text PDF

The MET Oncogene Network of Interacting Cell Surface Proteins.

Int J Mol Sci

December 2024

Department of Oncology, University of Turin, Regione Gonzole 10, 10143 Orbassano, Italy.

The MET oncogene, encoding the hepatocyte growth factor (HGF) receptor, plays a key role in tumorigenesis, invasion, and resistance to therapy, yet its full biological functions and activation mechanisms remain incompletely understood. A feature of MET is its extensive interaction network, encompassing the following: (i) receptor tyrosine kinases (RTKs); (ii) co-receptors (e.g.

View Article and Find Full Text PDF

Background: Metabolic syndrome (met-s) is a medical condition that includes abdominal obesity, hyperlipidemia, high blood glucose, and high blood pressure. It is associated with a high risk of developing cardiovascular diseases and type 2 diabetes mellitus. The condition was believed to be a challenge mostly faced by developed nations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!